A citation-based method for searching scientific literature

Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
Times Cited: 4498



Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn, William M Steinberg, Mette Stockner, Bernard Zinman, Richard M Bergenstal, John B Buse. N Engl J Med 2016
Times Cited: 3031




List of shared articles



Times cited

Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan).
Kenichi Shikata, Masakazu Haneda, Toshiharu Ninomiya, Daisuke Koya, Yoshiki Suzuki, Daisuke Suzuki, Hitoshi Ishida, Hiroaki Akai, Yasuhiko Tomino, Takashi Uzu,[...]. J Diabetes Investig 2021
3

Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes.
Jonas Ghouse, Paul Blanche, Morten W Skov, Bent Lind, Allan Vaag, Jørgen K Kanters, Jesper H Svendsen, Lars Køber, Morten S Olesen, Thomas A Gerds,[...]. Eur Heart J Cardiovasc Pharmacother 2021
1


Long-Term Weight Loss Strategies for Obesity.
Karim Kheniser, David R Saxon, Sangeeta R Kashyap. J Clin Endocrinol Metab 2021
2

The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.
Cyrielle Caussy, Adrien Aubin, Rohit Loomba. Curr Diab Rep 2021
2


Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Jack Wei Chieh Tan, David Sim, Junya Ako, Wael Almahmeed, Mark E Cooper, Jamshed J Dalal, Chaicharn Deerochanawong, David Wei Chun Huang, Sofian Johar, Upendra Kaul,[...]. Eur Cardiol 2021
0

Cardiovascular disease in diabetes, beyond glucose.
Robert H Eckel, Karin E Bornfeldt, Ira J Goldberg. Cell Metab 2021
2

Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type 2 diabetes in Japan.
Ryotaro Bouchi, Takehiro Sugiyama, Atsushi Goto, Kenjiro Imai, Noriko Ihana-Sugiyama, Mitsuru Ohsugi, Toshimasa Yamauchi, Takashi Kadowaki, Kohjiro Ueki. J Diabetes Investig 2021
0

Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin.
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, Yosuke Okada, Toshinari Takamura, Isao Taguchi, Shigeru Toyoda, Hirofumi Tomiyama, Shinichiro Ueda, Yukihito Higashi,[...]. Cardiovasc Diabetol 2021
0

Glucose-lowering therapy in patients undergoing percutaneous coronary intervention.
Isabelle Johansson, Ilaria Dicembrini, Edoardo Mannucci, Francesco Cosentino. EuroIntervention 2021
0

Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?
Theano Penlioglou, Anca Pantea Stoian, Nikolaos Papanas. J Clin Med 2021
1

Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology.
B Fuentes, S Amaro, M Alonso de Leciñana, J F Arenillas, O Ayo-Martín, M Castellanos, M Freijo, A García-Pastor, M Gomis, M Gómez Choco,[...]. Neurologia (Engl Ed) 2021
1

Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic-Cardio-Renal Perspective for the Primary Care Physician.
Roopa Mehta, Daniel Pichel, Chih Hao Chen-Ku, Pablo Raffaele, Antonio Méndez Durán, Francisco Padilla, Jose Javier Arango Alvarez, José Esteban Costa Gil, Juan Esteban Gómez Mesa, Mariano Giorgi,[...]. Diabetes Ther 2021
0

JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases.
Masakazu Yamagishi, Nagara Tamaki, Takashi Akasaka, Takanori Ikeda, Kenji Ueshima, Shiro Uemura, Yutaka Otsuji, Yasuki Kihara, Kazuo Kimura, Takeshi Kimura,[...]. Circ J 2021
4

Interpretation of clinical trials on the cardiovascular effects of hypoglycemic drugs in people with type2 diabetes.
Ana Romero, Gemma Llauradó, José-Miguel González-Clemente. Endocrinol Diabetes Nutr (Engl Ed) 2021
0

Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study.
Siyao He, Xin Qian, Yanyan Chen, Xiaoxia Shen, Bo Zhang, Xiaoping Chen, Xiangjin Xu, Guangwei Li. J Diabetes Res 2021
0

2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
Kyu Yeon Hur, Min Kyong Moon, Jong Suk Park, Soo-Kyung Kim, Seung-Hwan Lee, Jae-Seung Yun, Jong Ha Baek, Junghyun Noh, Byung-Wan Lee, Tae Jung Oh,[...]. Diabetes Metab J 2021
1